Click Here for 5% Off Your First Aladdin Purchase!

(±)-NBI 74330 - ≥96%, high purity , CAS No.473722-68-8, Antagonist of CXCR3

  • Moligand™
  • ≥96%
Item Number
N274909
Grouped product items
SKUSizeAvailabilityPrice Qty
N274909-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$190.90
N274909-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$292.90
N274909-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$658.90
N274909-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,185.90

Potent and selective CXCR3 antagonist

View related series
CXCR3 Antagonist

Basic Description

Synonymsrac-NBI-74330;racNBI74330;rac NBI 74330;N-[1-[3-(4-Ethoxyphenyl)-3,4-dihydro-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-4-fluoro-N-(3-pyridinylmethyl)-3-(trifluoromethyl)benzeneacetamide
Specifications & PurityMoligand™, ≥96%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionAntagonist of CXCR3
NoteRefer to SDS for further information Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

(±)-NBI 74330 is an effective and selective CXCR3 antagonist.

Associated Targets

CXCR3 Tchem C-X-C chemokine receptor type 3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HDAC6 Tclin Histone deacetylase 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name N-[1-[3-(4-ethoxyphenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]-N-(pyridin-3-ylmethyl)acetamide
INCHI InChI=1S/C32H27F4N5O3/c1-3-44-24-11-9-23(10-12-24)41-30(39-29-25(31(41)43)7-5-15-38-29)20(2)40(19-22-6-4-14-37-18-22)28(42)17-21-8-13-27(33)26(16-21)32(34,35)36/h4-16,18,20H,3,17,19H2,1-2H3
InChi Key XMRGQUDUVGRCBS-UHFFFAOYSA-N
Canonical SMILES CCOC1=CC=C(C=C1)N2C(=O)C3=C(N=CC=C3)N=C2C(C)N(CC4=CN=CC=C4)C(=O)CC5=CC(=C(C=C5)F)C(F)(F)F
Isomeric SMILES CCOC1=CC=C(C=C1)N2C(=O)C3=C(N=CC=C3)N=C2C(C)N(CC4=CN=CC=C4)C(=O)CC5=CC(=C(C=C5)F)C(F)(F)F
PubChem CID 10167713
Molecular Weight 605.58

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

8 results found

Lot NumberCertificate TypeDateItem
B2421646Certificate of AnalysisJan 11, 2024 N274909
B2421647Certificate of AnalysisJan 11, 2024 N274909
B2421648Certificate of AnalysisJan 11, 2024 N274909
B2421653Certificate of AnalysisJan 11, 2024 N274909
B2421655Certificate of AnalysisJan 11, 2024 N274909
B2421656Certificate of AnalysisJan 11, 2024 N274909
B2421657Certificate of AnalysisJan 11, 2024 N274909
B2421658Certificate of AnalysisJan 11, 2024 N274909

Chemical and Physical Properties

SolubilitySoluble in DMSO to 50 mM

Related Documents

References

1. Heise CE, Pahuja A, Hudson SC, Mistry MS, Putnam AL, Gross MM, Gottlieb PA, Wade WS, Kiankarimi M, Schwarz D et al..  (2005)  Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist..  J Pharmacol Exp Ther,  313  (3): (1263-71).  [PMID:15761110]

Solution Calculators